PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Pathology and Laboratory Medicine, The Lewis Katz School of Medicine at Temple University, Philadelphia, PA 19140, United States of America; Center for Substance Abuse Research, The Lewis Katz School of Medicine at Temple University, Philadelphia, PA 19140, United States of America.\', \'Department of Biomedical Engineering, Rowan University, Glassboro, NJ 08028, United States of America.\', \'Department of Pathology and Laboratory Medicine, The Lewis Katz School of Medicine at Temple University, Philadelphia, PA 19140, United States of America.\', \'Department of Pathology and Laboratory Medicine, The Lewis Katz School of Medicine at Temple University, Philadelphia, PA 19140, United States of America; Center for Substance Abuse Research, The Lewis Katz School of Medicine at Temple University, Philadelphia, PA 19140, United States of America; The Shriners Hospitals Pediatric Research Center, Philadelphia, PA 19140, United States of America. Electronic address: servio@temple.edu.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • S0969-9961(20)30406-X10.1016/j.nbd.2020.105131
?:hasPublicationType
?:journal
  • Neurobiology of disease
is ?:pmid of
?:pmid
?:pmid
  • 33053430
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 2.674
?:rankingScore_hIndex
  • 146
is ?:relation_isRelatedTo_publication of
?:title
  • The SARS-CoV-2 spike protein alters barrier function in 2D static and 3D microfluidic in-vitro models of the human blood-brain barrier.
?:type
?:year
  • 2020

Metadata

Anon_0  
expand all